Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Theranostics|May 28, 2019
EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoterFeng Shi, Min Zhou, Li Shang, et al.Journal of Medical Virology|April 29, 2024
Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinomaFeng Shi, Li Shang, Min Zhou, et al.Theranostics|June 6, 2022
Erratum: Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: ErratumJianmin Hu, Yueshuo Li, Hongde Li, et al.Theranostics|November 18, 2020
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapyJianmin Hu, Yueshuo Li, Hongde Li, et al.Signal Transduction and Targeted Therapy|May 21, 2020
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistanceLonglong Xie, Feng Shi, Yueshuo Li, et al.Molecular Metabolism|April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesisFeng Shi, Ya He, Jiangjiang Li, et al.NPJ Precision Oncology|March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replicationYueshuo Li, Feng Shi, Jianmin Hu, et al.Theranostics|August 22, 2018
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancerJiangjiang Li, Ya He, Zheqiong Tan, et al.Cell Death & Disease|April 12, 2022
CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinomaMin Tang, Xin Dong, Lanbo Xiao, et al.Pageof 7